TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast CancerRachel O. Abelman, Aditya Bardia, Steven J. Isakoff et al.|Clinical Cancer Research|2025Cited by 39
A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast CancerBogang Wu, Leif W. Ellisen, Elena Bitman et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 5